4 transcripts
APLS
Earnings call transcript
NASDAQ
2024 Q2
1 Aug 24
in this trial as the achievement of a statistically significant response to the primary endpoint as well as positive effects in some of the additional secondary
APLS
Earnings call transcript
NASDAQ
2024 Q1
7 May 24
patients at week 26 compared to baseline. Physicians consider a statistically significant response to the primary endpoint as clinically meaningful
APLS
Earnings call transcript
NASDAQ
2023 Q4
27 Feb 24
response in geographic atrophy. Again, there's like a resolution problem with that from what I understand, but Caroline can talk about that more.
What I
APLS
Earnings call transcript
NASDAQ
2023 Q2
31 Jul 23
IOI events and any antidrug antibodies, providing evidence that these events were unlikely to be caused by an immune response to either the peptide
- Prev
- 1
- Next